A prospective, standardised neuroimaging protocol was implemented to characterise mesial temporal lobe pathology in amyotrophic lateral sclerosis, Alzheimer's disease and healthy controls focusing on the evaluation of interconnected white and grey matter structures. "Hippocampal pathology in Amyotrophic Lateral Sclerosis: selective vulnerability of subfields and their associated projections" [1] . High-resolution diffusion tensor and structural imaging data were acquired on a 3 T MRI platform using standardised sequence parameters.
Data
The cerebral signature of Amyotrophic lateral sclerosis (ALS) is primarily associated with motor cortex [2, 3] , corpus callosum [4] , corticospinal tract [5] and brainstem pathology [6] . Precentral gyrus degeneration is a hallmark feature of ALS [7] , but extrapyramidal [8] and extra-motor [9] involvement are also increasingly recognised [10] . The hippocampal profile of ALS is poorly characterised and is seldom contrasted to disease-controls with other neurodegenerative conditions [11] . Clinical and imaging data were acquired from 50 amyotrophic lateral sclerosis patients, 18 patients with Alzheimer's disease and 40 healthy controls using a standardised magnetic resonance imaging protocol [1] . Diffusion tensor imaging data were processed to provide tract-wise fractional anisotropy (FA), radial (Drad) and axial (Dax) diffusivity values for the fornix and perforant pathway for each participant. High resolution, T1-weighted imaging with a voxel size of 1 mm Table 1 ).
Value of the Data
The majority of imaging data sets in amyotrophic lateral sclerosis focus on motor cortex and corticospinal tract integrity Raw volumetric hippocampal data in amyotrophic lateral sclerosis confirm selective subfield involvement Imaging data from amyotrophic lateral sclerosis and Alzheimer's disease reveal divergent mesial temporal lobe profiles Multimodal imaging data confirms the degeneration of interlinked white and grey matter components in ALS Imaging data from amyotrophic lateral sclerosis and disease controls may be used in machine learning applications Quantitative neuroimaging in amyotrophic lateral sclerosis may serve as a non-invasive biomarker of disease burden 
Experimental design, materials, and methods
Imaging data were acquired on a 3 T Philips Achieva-Tx MR scanner and the neuroimaging protocol included a 3D T1-weighted sequence (TR: 9.9 ms, TE: 3.7 ms, flip angle: 7ο, voxel-size 1 Â 1 Â 1 mm, matrix size 244 Â 240, 170 slices), a DTI sequence with 30 diffusion encoding directions (TR: 7299 ms, TE: 68 ms, flip angle: 90ο, field of view: 256 Â 256 mm, voxel size: 2 Â 2 Â 2 mm, 70 slices) and FLAIR imaging (TR: 11000 ms, TI: 2800 ms, TE: 125 ms, acquisition matrix 384 Â 186, slice thickness 4 mm). The Brainance DTI Suite (Advantis Medical Imaging, Eindhoven, the Netherlands) was used for white matter tractography and the reconstruction of the fornix and perforant pathway, following motion and eddy-current corrections. An FA threshold of 0.20 and an angle threshold of 6 were used for perforant pathway reconstruction. An FA threshold of 0.25 and an angle threshold of 60 were used for fornix tractography. The following white matter metrics were generated for each tract: fractional anisotropy (FA); axial diffusivity (Dax); and radial diffusivity (Drad). Total intracranial volumes (TIV) were calculated using FSL-FLIRT [13] and FSL-FAST [14, 15] and hippocampal segmentation was performed using version 6.0 of the FreeSurfer image analysis suite. The following subfields were evaluated: CA1, CA2/3, CA4, fimbria, hippocampal fissure, presubiculum, subiculum, hippocampal tail, parasubiculum, molecular layer; granule cell layer of the dentate gyrus (GC-DG), hippocampal-amygdala transition area (HATA).
